Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


12.11.2018

11 AIDS
4 AIDS Res Hum Retroviruses
1 Antimicrob Agents Chemother
2 BMC Cancer
2 Clin Infect Dis
1 Drugs
2 HIV Med
7 J Acquir Immune Defic Syndr
3 J Virol
1 Lancet
1 Lancet Haematol
2 Lancet HIV
1 N Engl J Med
2 Nat Med
1 Nat Rev Immunol
2 PLoS Med
14 PLoS One
2 PLoS Pathog
1 Vaccine
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. FOX J, Collins S
    HIV prevention: response to pre-exposure prophylaxis failure with tenofovir disoproxil.
    AIDS. 2017;31:1343.
    PubMed     Text format    

  2. LE ROUX SM, Abrams EJ, Jao J, Malaba T, et al
    Response to 'In-utero exposure to tenofovir is associated with impaired fetal and infant growth' by Denneman et al.
    AIDS. 2017;31:595-596.
    PubMed     Text format    

  3. DENNEMAN L, Cohen S, Godfried MH, van Leeuwen E, et al
    In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants: author's reply.
    AIDS. 2017;31:596-598.
    PubMed     Text format    

  4. ESSER S, Streeck H
    Preexposure prophylaxis failure with tenofovir disoproxil.
    AIDS. 2017;31:1344.
    PubMed     Text format    

  5. WEINSTEIN M, Yang OO, Cohen AC
    Were we prepared for PrEP? five years of implementation.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001626.
    PubMed     Text format     Abstract available

  6. SUNDERMANN EE, Heaton RK, Pasipanodya E, Moore RC, et al
    Sex differences in HIV-associated cognitive impairment.
    AIDS. 2018;32:2719-2726.
    PubMed     Text format     Abstract available


  7. Non-Hodgkin lymphoma risk in adults living with HIV across five continents.
    AIDS. 2018;32:2777-2786.
    PubMed     Text format     Abstract available

  8. NYANHETE T, Tomaras GD
    CD8+ T cells: mechanistic target of rapamycin and eukaryotic initiation factor 2 in elite HIV-1 control.
    AIDS. 2018;32:2835-2838.
    PubMed     Text format    

  9. GUNST JD
    New insight into the mechanisms of achieving antiretroviral therapy-free HIV-1 control.
    AIDS. 2018;32:2839-2840.
    PubMed     Text format    

  10. SLOGROVE AL, Powis KM, Bettinger JA, Cotton MF, et al
    Considerations in evaluating infectious morbidity and mortality in HIV-exposed uninfected infants.
    AIDS. 2018;32:2855-2856.
    PubMed     Text format    


  11. Transcriptional gene silencing limits CXCR4-associated depletion of bone marrow CD34+ cells in HIV-1 infection: Erratum.
    AIDS. 2018;32:2857-2858.
    PubMed     Text format    


    AIDS Res Hum Retroviruses

  12. O'CONNOR MA, Munson PV, Tunggal H, Hajari N, et al
    Mucosal T helper 17 and T regulatory cell homeostasis correlates with acute SIV viremia and responsiveness to antiretroviral therapy in macaques.
    AIDS Res Hum Retroviruses. 2018 Nov 6. doi: 10.1089/AID.2018.0184.
    PubMed     Text format     Abstract available

  13. DASGUPTA S, France AM, Brandt MG, Reuer J, et al
    Estimating effects of HIV sequencing data completeness on transmission network patterns and detection of growing HIV transmission clusters.
    AIDS Res Hum Retroviruses. 2018 Nov 7. doi: 10.1089/AID.2018.0181.
    PubMed     Text format     Abstract available

  14. HALEYUR GIRI SETTY MK, Kurdekar A, Mahtani P, Liu J, et al
    Cross-subtype Detection of HIV-1 capsid p24 antigen using a Sensitive Europium Nanoparticle Assay.
    AIDS Res Hum Retroviruses. 2018 Nov 9. doi: 10.1089/AID.2018.0163.
    PubMed     Text format     Abstract available

  15. ZHANG J, Wang N, He L, Pan X, et al
    Discordance of HIV-1 viral load from paired blood and seminal plasma samples in a Chinese MSM population.
    AIDS Res Hum Retroviruses. 2018 Nov 9. doi: 10.1089/AID.2018.0090.
    PubMed     Text format     Abstract available


    Antimicrob Agents Chemother

  16. KWARA A, Yang H, Antwi S, Enimil A, et al
    Effect of rifampin/isoniazid-containing antituberculosis therapy on efavirenz pharmacokinetics in HIV-infected children aged 3 to 14 years old.
    Antimicrob Agents Chemother. 2018 Nov 5. pii: AAC.01657.
    PubMed     Text format     Abstract available


    BMC Cancer

  17. NAGATA N, Nishijima T, Niikura R, Yokoyama T, et al
    Increased risk of non-AIDS-defining cancers in Asian HIV-infected patients: a long-term cohort study.
    BMC Cancer. 2018;18:1066.
    PubMed     Text format     Abstract available

  18. KIM SE, Jung Y, Oh TH, Kim UJ, et al
    Case report: dual primary AIDS-defining cancers in an HIV-infected patient receiving antiretroviral therapy: Burkitt's lymphoma and Kaposi's sarcoma.
    BMC Cancer. 2018;18:1080.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  19. JOAG V, Obila O, Gajer P, Scott MC, et al
    Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility.
    Clin Infect Dis. 2018 Sep 12. pii: 5167090. doi: 10.1093.
    PubMed     Text format     Abstract available

  20. DONDERS GGG, Ruban K, Depuydt C, Bellen G, et al
    Treatment Attitudes for Belgian Women With Persistent Trichomonas vaginalis Infection in the VlaResT Study.
    Clin Infect Dis. 2018 Oct 12. pii: 5158479. doi: 10.1093.
    PubMed     Text format     Abstract available


    Drugs

  21. BLAIR HA
    Dolutegravir/Rilpivirine: A Review in HIV-1 Infection.
    Drugs. 2018 Nov 8. pii: 10.1007/s40265-018-1005.
    PubMed     Text format     Abstract available


    HIV Med

  22. ROTMAN L, Luo X, Thompson A, Mackesy-Amiti ME, et al
    Risk of neurosyphilis in HIV-infected persons with syphilis lacking signs or symptoms of central nervous system infection.
    HIV Med. 2018 Nov 7. doi: 10.1111/hiv.12677.
    PubMed     Text format     Abstract available

  23. GAMEIRO J, Agapito Fonseca J, Jorge S, Lopes JA, et al
    Acute kidney injury in HIV-infected patients: a critical review.
    HIV Med. 2018 Nov 8. doi: 10.1111/hiv.12685.
    PubMed     Text format     Abstract available


    J Acquir Immune Defic Syndr

  24. CHOUDHARY RK, Wall KM, Njuguna I, Pavlinac PB, et al
    Monocyte-to-lymphocyte ratio is associated with tuberculosis disease and declines with anti-TB treatment in HIV-infected children.
    J Acquir Immune Defic Syndr. 2018 Oct 26. doi: 10.1097/QAI.0000000000001893.
    PubMed     Text format     Abstract available

  25. FAYORSEY RN, Wang C, Chege D, Reidy W, et al
    Effectiveness of a lay counsellor-led combination intervention for retention of mothers and infants in HIV care: A randomized trial in Kenya.
    J Acquir Immune Defic Syndr. 2018 Nov 5. doi: 10.1097/QAI.0000000000001882.
    PubMed     Text format     Abstract available

  26. MEYA DB, Kiragga AN, Nalintya E, Morawski BM, et al
    Reflexive laboratory-based cryptococcal antigen screening and preemptive fluconazole therapy for cryptococcal antigenemia in HIV-infected individuals with CD4 <100 cells/microL: a stepped-wedge, cluster-randomized trial.
    J Acquir Immune Defic Syndr. 2018 Nov 5. doi: 10.1097/QAI.0000000000001894.
    PubMed     Text format     Abstract available

  27. LAM A, Mayo NE, Scott S, Brouillette MJ, et al
    HIV-Related Stigma Affects Cognition in Older Men Living with HIV.
    J Acquir Immune Defic Syndr. 2018 Oct 26. doi: 10.1097/QAI.0000000000001898.
    PubMed     Text format     Abstract available

  28. ARRINGTON-SANDERS R, Wilson CM, Perumean-Chaney SE, Patki A 2nd, et al
    The role of socio-behavioral factors in sub-protective tenofovir diphosphate (TFV-DP) levels among YMSM enrolled in two PrEP trials.
    J Acquir Immune Defic Syndr. 2018 Oct 26. doi: 10.1097/QAI.0000000000001901.
    PubMed     Text format     Abstract available

  29. SCHNOLL RA, Thompson M, Serrano K, Leone F, et al
    Rate of Nicotine Metabolism and Tobacco Use among Persons with HIV: Implications for Treatment and Research.
    J Acquir Immune Defic Syndr. 2018 Oct 26. doi: 10.1097/QAI.0000000000001895.
    PubMed     Text format     Abstract available

  30. GHIGLIONE Y, Trifone C, Salido J, Rhodes A, et al
    PD-1 expression in HIV-specific CD8+ T-cells prior to antiretroviral therapy is associated with HIV persistence.
    J Acquir Immune Defic Syndr. 2018 Oct 26. doi: 10.1097/QAI.0000000000001887.
    PubMed     Text format     Abstract available


    J Virol

  31. LIU Z, Torresilla C, Xiao Y, Nguyen PT, et al
    HIV-1 antisense protein of different clades induces autophagy and associates to the autophagy factor p62.
    J Virol. 2018 Nov 7. pii: JVI.01757-18. doi: 10.1128/JVI.01757.
    PubMed     Text format     Abstract available

  32. STEFIC K, Bouvin-Pley M, Essat A, Visdeloup C, et al
    Sensitivity to Broadly Neutralizing Antibodies of Recently Transmitted HIV-1 Clade CRF02_AG Viruses with a Focus on Evolution over Time.
    J Virol. 2018 Nov 7. pii: JVI.01492-18. doi: 10.1128/JVI.01492.
    PubMed     Text format     Abstract available

  33. KWAA AKR, Talana CAG, Blankson JN
    Interferon-alpha Enhances NK Cell Function and the Suppressive Capacity of HIV-specific CD8+ T Cells.
    J Virol. 2018 Nov 7. pii: JVI.01541-18. doi: 10.1128/JVI.01541.
    PubMed     Text format     Abstract available


    Lancet

  34. THE LANCET
    Active case finding for communicable diseases in prisons.
    Lancet. 2018;391:2186.
    PubMed     Text format    


    Lancet Haematol

  35. POPAT UR, Mehta RS, Bassett R, Chen J, et al
    Fludarabine with a higher versus lower dose of myeloablative timed-sequential busulfan in older patients and patients with comorbidities: an open-label, non-stratified, randomised phase 2 trial.
    Lancet Haematol. 2018;5:e532-e542.
    PubMed     Text format     Abstract available


    Lancet HIV

  36. ESBJORNSSON J, Mansson F, Kvist A, da Silva ZJ, et al
    Long-term follow-up of HIV-2-related AIDS and mortality in Guinea-Bissau: a prospective open cohort study.
    Lancet HIV. 2018 Nov 1. pii: S2352-3018(18)30254.
    PubMed     Text format     Abstract available

  37. WEJSE C, Honge BL
    Is it time to revise the notion that HIV-2 is benign?
    Lancet HIV. 2018 Nov 1. pii: S2352-3018(18)30265.
    PubMed     Text format    


    N Engl J Med

  38. BLANK S, Daskalakis DC
    Neisseria gonorrhoeae - Rising Infection Rates, Dwindling Treatment Options.
    N Engl J Med. 2018;379:1795-1797.
    PubMed     Text format    


    Nat Med

  39. CHURCHYARD GJ
    A stratified approach to tuberculosis treatment.
    Nat Med. 2018;24:1639-1641.
    PubMed     Text format    

  40. IMPERIAL MZ, Nahid P, Phillips PPJ, Davies GR, et al
    A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis.
    Nat Med. 2018;24:1708-1715.
    PubMed     Text format     Abstract available


    Nat Rev Immunol

  41. DAVENPORT MP, Khoury DS, Cromer D, Lewin SR, et al
    Functional cure of HIV: the scale of the challenge.
    Nat Rev Immunol. 2018 Nov 8. pii: 10.1038/s41577-018-0085.
    PubMed     Text format     Abstract available


    PLoS Med

  42. ALEXANDER KA, Heaney AK, Shaman J
    Hydrometeorology and flood pulse dynamics drive diarrheal disease outbreaks and increase vulnerability to climate change in surface-water-dependent populations: A retrospective analysis.
    PLoS Med. 2018;15:e1002688.
    PubMed     Text format     Abstract available

  43. LANDOVITZ RJ, Li S, Grinsztejn B, Dawood H, et al
    Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.
    PLoS Med. 2018;15:e1002690.
    PubMed     Text format     Abstract available


    PLoS One

  44. ARRIVE E, Viard JP, Salanave B, Dollfus C, et al
    Metabolic risk factors in young adults infected with HIV since childhood compared with the general population.
    PLoS One. 2018;13:e0206745.
    PubMed     Text format     Abstract available

  45. KASAIE P, Radford M, Kapoor S, Jung Y, et al
    Economic and epidemiologic impact of guidelines for early ART initiation irrespective of CD4 count in Spain.
    PLoS One. 2018;13:e0206755.
    PubMed     Text format     Abstract available

  46. LIMAYE NP, Rivas-Nieto AC, Carcamo CP, Blas MM, et al
    Nuestras Historias- Designing a novel digital story intervention through participatory methods to improve maternal and child health in the Peruvian Amazon.
    PLoS One. 2018;13:e0205673.
    PubMed     Text format     Abstract available

  47. DEGROAT AR, Fleming CK, Dunlay SM, Hagood KL, et al
    The sex specific effect of alcohol consumption on circulating levels of CTRP3.
    PLoS One. 2018;13:e0207011.
    PubMed     Text format     Abstract available

  48. LIPPMAN SA, Gilmore HJ, Lane T, Radebe O, et al
    Ability to use oral fluid and fingerstick HIV self-testing (HIVST) among South African MSM.
    PLoS One. 2018;13:e0206849.
    PubMed     Text format     Abstract available

  49. VAN DE WATER BJ, Silva SG, Prvu Bettger J, Humphreys J, et al
    Provision of guideline-based care for drug-resistant tuberculosis in South Africa: Level of concordance between prescribing practices and guidelines.
    PLoS One. 2018;13:e0203749.
    PubMed     Text format     Abstract available

  50. CANNON L, Vargas-Garcia CA, Jagarapu A, Piovoso MJ, et al
    HIV 2-LTR experiment design optimization.
    PLoS One. 2018;13:e0206700.
    PubMed     Text format     Abstract available

  51. WOMACK JA, Novick G, Fried T
    The beginning of the end: A qualitative study of falls among HIV+ individuals.
    PLoS One. 2018;13:e0207006.
    PubMed     Text format     Abstract available

  52. HAUSER A, Hofmann A, Meixenberger K, Altmann B, et al
    Increasing proportions of HIV-1 non-B subtypes and of NNRTI resistance between 2013 and 2016 in Germany: Results from the national molecular surveillance of new HIV-diagnoses.
    PLoS One. 2018;13:e0206234.
    PubMed     Text format     Abstract available

  53. KADIMA J, Patterson E, Mburu M, Blat C, et al
    Adoption of routine virologic testing and predictors of virologic failure among HIV-infected children on antiretroviral treatment in western Kenya.
    PLoS One. 2018;13:e0200242.
    PubMed     Text format     Abstract available

  54. SIRIVONGRANGSON P, Girdthep N, Sukwicha W, Buasakul P, et al
    The first year of the global Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) in Bangkok, Thailand, 2015-2016.
    PLoS One. 2018;13:e0206419.
    PubMed     Text format     Abstract available

  55. LOQUIHA O, Hens N, Chavane L, Temmerman M, et al
    Mapping maternal mortality rate via spatial zero-inflated models for count data: A case study of facility-based maternal deaths from Mozambique.
    PLoS One. 2018;13:e0202186.
    PubMed     Text format     Abstract available

  56. PERRIAT D, Plazy M, Gumede D, Boyer S, et al
    "If you are here at the clinic, you do not know how many people need help in the community": Perspectives of home-based HIV services from health care workers in rural KwaZulu-Natal, South Africa in the era of universal test-and-treat.
    PLoS One. 2018;13:e0202473.
    PubMed     Text format     Abstract available

  57. ADUSEI KA, Owusu-Ofori A
    Prevalence of Plasmodium parasitaemia in blood donors and a survey of the knowledge, attitude and practices of transfusion malaria among health workers in a hospital in Kumasi, Ghana.
    PLoS One. 2018;13:e0206303.
    PubMed     Text format     Abstract available


    PLoS Pathog

  58. LEOZ M, Kukanja P, Luo Z, Huang F, et al
    HEXIM1-Tat chimera inhibits HIV-1 replication.
    PLoS Pathog. 2018;14:e1007402.
    PubMed     Text format     Abstract available

  59. LABRANCHE CC, McGuire AT, Gray MD, Behrens S, et al
    HIV-1 Envelope Glycan Modifications that Permit Neutralization by Germline-Reverted VRC01-Class Broadly Neutralizing Antibodies.
    PLoS Pathog. 2018;14:e1007431.
    PubMed     Text format     Abstract available


    Vaccine

  60. JI Y, Han X, Tian W, Gao Y, et al
    V4 region of the HIV-1 envelope gene mediates immune escape and may not promote the development of broadly neutralizing antibodies.
    Vaccine. 2018 Oct 30. pii: S0264-410X(18)31471.
    PubMed     Text format     Abstract available


    Virology

  61. LI H, Chen BK
    Variable infectivity and conserved engagement in cell-to-cell viral transfer by HIV-1 Env from Clade B transmitted founder clones.
    Virology. 2018;526:189-202.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: